AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 41 min read$AYI

HOLCOM KAREN J sold $659K of AYI

HOLCOM KAREN J (SVP & Chief Financial Officer) sold 2,000 shares of ACUITY INC. (DE) (AYI) at $329.62 ($0.66M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HOLCOM KAREN J
Published Sep 4, 2026, 12:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AYI
Bearish
medium confidence
Mentioned
$AYI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AYIBearishLow
01

Why it matters

A CFO's sale, even modest, can be interpreted as a negative signal, but the pre‑arranged nature tempers impact.

02

Market read

The filing provides fresh, material information about insider activity, warranting brief attention but limited trading urgency.

03

What to watch

The 10b5-1 plan pre‑arranges sales, reducing the signaling value of the transaction.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑01

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$AYIBearishMedium confidence
Context

CFO Karen J. Holcom sold 2,000 shares for $659,240 via a 10b5-1 plan, reducing her stake to 17,447 shares.

Expected impact

Potential modest dip of 1‑2% in the near term.

Evidence & confidence

While the amount is modest relative to market cap, CFO sales are closely watched and can trigger short‑term selling pressure.

Market effects

Sector

Minimal; the sale does not affect the broader medical device sector.

Regional

None; the filing is U.S. specific and limited to Acuity.

Global

Low; no cross‑border implications.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to company outlook; investors may ignore it.

Key entities

  • Officer
    Karen J. Holcom

    Senior Vice President & Chief Financial Officer of Acuity Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AYI insider trading history →

Related articles

OCT 2
$ACNHighAI 8/10

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

finance.yahoo.com2 min
OCT 2
$AYIMedAI 8/10

AYI Q3 Deep Dive: Margin Expansion Outpaces Revenue Growth Amid Mixed Top-Line Results

Acuity Brands (AYI) reported Q3 revenue of $1.24B, up 2.9% YoY, missing estimates but exceeding EPS expectations with $5.77 per share. Management highlighted margin expansion in lighting and growth in Intelligent Spaces, offset by softer lighting market performance. Future challenges include higher memory costs, while opportunities lie in new verticals and innovation.

financialcontent.com2 min
OCT 2
$AYIMedAI 8/10

Acuity (AYI) Stock Slips As AIS Gains Meet Memory Cost Pressure

Acuity (AYI) stock fell 3.4% to $299.28, despite Q4 revenue growth of 2.9% and EPS increase of 55.4%. Acuity Intelligent Spaces (AIS) grew to 25% of revenue, boosting margins. However, memory cost pressures and flat ABL sales raised concerns. Net income rose 51.8% to $173.0M, with net profit margin improving to 11.4%.

simplywall.st4 min
OCT 2
$AYIHighAI 8/10

Acuity (AYI) Q4 2026 Earnings Call Transcript

Acuity Brands (AYI) reported Q4 2026 net sales of $4.6B, up 6.8% YoY, driven by its intelligent spaces portfolio. Adjusted EPS rose 11% to $5.77, while gross margin expanded 130 bps to 50.2%. The lighting segment saw a 0.4% sales decline, while intelligent spaces grew 16.6%. Fiscal 2027 guidance: $4.7B-$4.9B revenue, $20.50-$22.00 EPS. The company repurchased $287M in shares and fully repaid QSC acquisition debt.

fool.com3 min
OCT 1
$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

cnbc.com3 min